Use of endothelial progenitor cell capture stent (Genous Bio-Engineered R Stent) during primary percutaneous coronary intervention in acute myocardial infarction: Intermediate- to long-term clinical follow-up
To access this article, please choose from the options below
The study complies with the Declaration of Helsinki. The ethics committee of the National Health Care Group Domain Specific Review Board (DSRB) C has approved the research protocol. Informed consent was obtained from the subjects and/or their guardians for the study.
PII: S0002-8703(07)00767-3
doi:10.1016/j.ahj.2007.08.031
© 2008 Published by Elsevier Inc.
